Page 7 - Human Data News Today

Integrated Partner Ecosystem and Solutions Unlock Value of Health and Wellbeing Investments PROVIDENCE, R.I., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Virgin Pulse (https://www.virginpulse.com/), the leading

Investegate announcements from Virgin Pulse, Virgin Pulse Adds 7 Partners to Homebase for Health®, Expanding Global Options for Addressing Top Corporate Health and Wellbeing Concerns

The University of Maryland, Baltimore (UMB) is the state’s public health, law, and human services university devoted to excellence in professional and graduate education, research, patient care, and public service.

Despite the substantial impact of the COVID-19 pandemic on patient care during 2020, the scientific advances in oncology continued, with 3,500 new drugs in the pipeline in 2020, up 75 percent since 2015. Oncologists worldwide report caseloads that are 26 to 51 percent lower than pre-pandemic levels, resulting in ...

Opioid Crisis Fast Facts Here’s a look at the opioid crisis. Opioids are drugs formulated to replicate the pain-reducing properties of opium. Prescription painkillers like morphine, oxycodone and hydrocodone are opioids. Illegal drugs like heroin and illicitly made fentanyl are also opioids. The word “opioid” is derived from the word “opium.” Common Opioids Hydrocodone and oxycodone are semi-synthetic opioids, manufactured in labs with natural and synthetic ingredients. Fentanyl is a ...

Despite COVID-19, pharma R&D funding at all-time high: IQVIA According to the clinical research solutions firm, disruptions due to the pandemic did not stop the industry from fueling R&D at unprecedented levels. The IQVIA Institute for Human Data Science has released its latest industry latest report, Global Trends in R&D: Overview Through 2020. According to the findings, research and development funding maintained historically high levels, thanks to new funding sour...

Print this article Democratic legislation aimed at prescription drugs could sacrifice future savings in healthcare to reduce costs in the short term. House Democrats have proposed HR 3, a bill that would require the federal government to negotiate prices with drug manufacturers. The negotiated price of a drug could not exceed 120% of the average price of that drug in countries where costs are lower, including Australia, Canada, France, Germany, Japan, and the United Kingdom. But that could red...

Google to release new AI tool to identify skin conditions Google to release new AI tool to identify skin conditions Getty Images Google plans to release a new tool later this year that will use artificial intelligence to help users identify problems with their skin, hair and nails, the company said Tuesday during its annual developer conference. The innovation will compete against one of the most lucrative specialties in the industry. "As a doctor, I often see patients when its too late," said...

Decision not to review Federal Circuit July 2020 ruling continues to prevent Sandoz launch of more affordable Erelzi treatment option for US patients Sandoz is disappointed US patients

, 2021 – Sandoz, a global leader in biosimilar and generic medicines, today announced that the US Supreme Court has denied its petition to review the Federal Circuit’s July 2020 decision concerning the Sandoz biosimilar Erelzi ® (etanercept-szzs) for reference medicine Enbrel ®* (etanercept). The Federal Circuit previously ruled against Sandoz in a divided decision upholding Amgen’s patents. “We are disappointed the Supreme Court decided not to review our case,” said Keren Haruvi, ...